AMI patients exhibited further elevation of IFITM1/2/3 compared to patients with stable CAD (p < 0.0001), with IFITM1 specifically upregulated in AMI with heart failure (3.07 vs. 4.64 ng/mL, p = 0.003). The gene discussed is IFITM1; the disease is coronary artery disorder.